JITSUBO Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Feb 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Oct 28, 2027The maintenance fee for Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method (US 10,633,418) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,293,948 | Reagent for organic synthesis and method of organic synthesis reaction with the reagent In force · From the USPTO record | In force | From the USPTO record | |
| US 8,093,435 | Reagent for organic synthesis and method of organic synthesis reaction with the reagent In force · From the USPTO record | In force | From the USPTO record | |
| US 8,633,298 | Carrier for separation, method for separation of compound, and method for synthesis of peptide using the carrier In force · From the USPTO record | In force | From the USPTO record | |
| US 9,376,467 | Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method In force · From the USPTO record | In force | From the USPTO record | |
| US 10,633,418 | Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method In force · From the USPTO record | In force | From the USPTO record | |
| US 9,365,615 | Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method In force · From the USPTO record | In force | From the USPTO record | |
| US 10,654,891 | Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method In force · From the USPTO record | In force | From the USPTO record | |
| US 11,098,078 | Peptide synthesis method In force · From the USPTO record | In force | From the USPTO record | |
| US 11,420,997 | Peptide synthesis method In force · From the USPTO record | In force | From the USPTO record | |
| US 9,284,348 | Method for synthesis of peptide using a carrier In force Ended no later than Sep 20, 2026 · From the USPTO record | In force | Ended no later than Sep 20, 2026 | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
Every application published under this name has become a patent.